Project Grant K01HL181327
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded $169,992 to the University of Colorado-Denver on September 18, 2025, to support a mixed-methods research study titled "Start Strong." This K01 mentored career development award funds research investigating optimal antihypertensive medication initiation strategies and will generate evidence for a future pragmatic trial testing a...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $881,454 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 15, 2026, with completion expected March 31, 2031. The grant supports the SUPERHERO (Study of the Epidemiology of Pediatric Hypertension) Registry, which will establish standardized methods to harmonize and analyze longitudinal data from 45,000 youth across...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $189,000 to the University of Colorado-Denver on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a proof-of-principle study investigating environmental predictors of treatment responsiveness for pediatric acute asthma exacerbations. The research addresses the clinical challenge that treatment response to standard protocols for asthma exacerbations in...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $150,104 to the Regents of the University of Colorado (University of Colorado-Denver) on January 26, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Lysine Myristoylation as a Novel Mechanism for Regulating PKA in the Heart," will be completed by December 31, 2028. The research investigates an alternative mechanism to activate protein kinase A (PKA)...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $198,654 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, through July 31, 2030. This award supports a five-year research initiative investigating the role of diet quality and food insecurity as modifiable factors linking socioeconomic status to Chronic Obstructive Pulmonary Disease (COPD) morbidity and...
- Federal Grant Award Summary Temple University received a $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2027. Under this R03 award, Principal Investigator Gabriella McLoughlin, PhD, MS, will conduct research investigating the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1,532,545 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for February 29, 2028. The project examines the effects of income-based health insurance benefit designs on cardiovascular disease (CVD) outcomes and health disparities among working-age adults. Specifically, the...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Tufts University School of Medicine a $1.12 million Project Grant (CFDA 93.837, Cardiovascular Diseases Research) on September 17, 2025, to conduct a multiethnic and multiomics analysis of longitudinal changes in DNA methylation (DNAM) and cardiovascular health. The four-year research initiative, concluding July 31, 2029, integrates longitudinal epigenome-wide DNAM data with behavioral, clinical, genetic,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $609,850 Project Grant to William Marsh Rice University on August 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a prospective, longitudinal biobehavioral study examining food insecurity as a social determinant of cardiovascular health in marginalized Latino immigrant populations. The four-year research initiative (through May 31, 2029) will collect mixed-methods data...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $166,968 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on September 15, 2025, with completion targeted for June 30, 2030. This research initiative delivers a community-engaged intervention study designed to reduce ultra-processed food (UPF) consumption in preschool children, specifically toddlers aged 2–3 years, to improve cardiovascular health...
The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Denver a Project Grant totaling $169,638 (awarded July 15, 2026) under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the relationship between neighborhood food access and cardiovascular disease (CVD) risk in early childhood. The research leverages two prospective cohorts—the geographically diverse Environmental Influences on Child Health Outcomes (ECHO) cohort and the Denver-based CARE cohort—to examine whether limited access to healthy foods in residential neighborhoods predicts obesogenic feeding practices, poor dietary quality, and elevated CVD risk markers in young children. Using geocoded address data and Geographic Information System (GIS) analysis, the study will create census tract-level and individual child-level measures of food access density to test mechanistic hypotheses linking neighborhood food environment to parental feeding behaviors, child dietary intake, eating behaviors, and physiological CVD risk indicators (body mass index, body fat, and blood pressure) measured between ages 2 and 5 years. The project will be completed by June 30, 2031, and represents investigator-initiated mechanistic research aligned with NHLBI's portfolio emphasis on understanding cardiovascular disease origins and prevention strategies in high-risk populations. As a prime recipient, the University of Denver will conduct the research at its Denver, Colorado location, contributing specialized expertise in child health outcomes and longitudinal cohort analysis to advance early-life CVD prevention science.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $169.6k | 7/15/26 |